PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gtf2i
|
ENSMUSG00000060261.17 | Gtf2i |
Gtf2f1
|
ENSMUSG00000002658.10 | Gtf2f1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gtf2i | mm39_v1_chr5_-_134343532_134343614 | 0.40 | 5.3e-04 | Click! |
Gtf2f1 | mm39_v1_chr17_-_57318271_57318326 | 0.26 | 2.5e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_69909245 | 15.14 |
ENSMUST00000231415.2
ENSMUST00000108588.9 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr2_+_136555364 | 12.00 |
ENSMUST00000028727.11
ENSMUST00000110098.4 |
Snap25
|
synaptosomal-associated protein 25 |
chrX_-_71699740 | 11.78 |
ENSMUST00000055966.13
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr13_+_42862957 | 11.55 |
ENSMUST00000066928.12
ENSMUST00000148891.8 |
Phactr1
|
phosphatase and actin regulator 1 |
chr15_-_66820265 | 9.31 |
ENSMUST00000167817.8
|
Ndrg1
|
N-myc downstream regulated gene 1 |
chr3_+_159545309 | 9.27 |
ENSMUST00000068952.10
ENSMUST00000198878.2 |
Wls
|
wntless WNT ligand secretion mediator |
chr16_+_95058417 | 9.13 |
ENSMUST00000113861.8
ENSMUST00000113854.8 ENSMUST00000113862.8 ENSMUST00000037154.14 ENSMUST00000113855.8 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr7_-_127423641 | 8.63 |
ENSMUST00000106267.5
|
Stx1b
|
syntaxin 1B |
chr16_-_42160957 | 8.54 |
ENSMUST00000102817.5
|
Gap43
|
growth associated protein 43 |
chr7_+_43959637 | 8.38 |
ENSMUST00000107938.8
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chr13_-_78347876 | 8.27 |
ENSMUST00000091458.13
|
Nr2f1
|
nuclear receptor subfamily 2, group F, member 1 |
chr11_-_118800314 | 8.20 |
ENSMUST00000117731.8
ENSMUST00000106278.9 ENSMUST00000120061.8 ENSMUST00000017576.11 |
Rbfox3
|
RNA binding protein, fox-1 homolog (C. elegans) 3 |
chr6_-_77956635 | 8.16 |
ENSMUST00000161846.8
ENSMUST00000160894.8 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr11_+_69909659 | 7.98 |
ENSMUST00000232002.2
ENSMUST00000134376.10 ENSMUST00000231221.2 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr14_-_55354392 | 7.94 |
ENSMUST00000022819.13
|
Jph4
|
junctophilin 4 |
chr17_+_27160356 | 7.93 |
ENSMUST00000229490.2
ENSMUST00000201702.5 ENSMUST00000177932.7 ENSMUST00000201349.6 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr19_+_6547790 | 7.93 |
ENSMUST00000113458.8
ENSMUST00000113459.2 |
Nrxn2
|
neurexin II |
chr1_-_172034251 | 7.90 |
ENSMUST00000155109.2
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr6_-_77956499 | 7.89 |
ENSMUST00000159626.8
ENSMUST00000075340.12 ENSMUST00000162273.2 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr16_-_74208180 | 7.81 |
ENSMUST00000117200.8
|
Robo2
|
roundabout guidance receptor 2 |
chr17_+_37357451 | 7.77 |
ENSMUST00000172789.2
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr16_+_95058505 | 7.76 |
ENSMUST00000113856.8
ENSMUST00000125847.2 ENSMUST00000134166.8 ENSMUST00000140222.8 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr15_-_84331236 | 7.72 |
ENSMUST00000080751.10
ENSMUST00000239449.2 |
Shisal1
|
shisa like 1 |
chr4_-_25800083 | 7.37 |
ENSMUST00000084770.5
|
Fut9
|
fucosyltransferase 9 |
chr13_+_91609264 | 7.15 |
ENSMUST00000231481.2
|
Ssbp2
|
single-stranded DNA binding protein 2 |
chr1_-_168259465 | 7.06 |
ENSMUST00000176540.8
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr14_+_55747902 | 7.01 |
ENSMUST00000165262.8
ENSMUST00000074225.11 |
Cpne6
|
copine VI |
chr2_+_143388062 | 7.00 |
ENSMUST00000028905.10
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr9_+_58489523 | 7.00 |
ENSMUST00000177292.8
ENSMUST00000085651.12 ENSMUST00000176557.8 ENSMUST00000114121.11 ENSMUST00000177064.8 |
Nptn
|
neuroplastin |
chr5_+_57875309 | 6.89 |
ENSMUST00000191837.6
ENSMUST00000068110.10 |
Pcdh7
|
protocadherin 7 |
chr7_-_45016138 | 6.88 |
ENSMUST00000211067.2
ENSMUST00000003961.16 |
Ppfia3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr2_+_58991182 | 6.84 |
ENSMUST00000168631.8
ENSMUST00000102754.11 ENSMUST00000123908.8 |
Pkp4
|
plakophilin 4 |
chr17_+_37356872 | 6.82 |
ENSMUST00000174456.8
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr10_+_13841819 | 6.57 |
ENSMUST00000187083.7
|
Hivep2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr13_-_105191403 | 6.42 |
ENSMUST00000063551.7
|
Rgs7bp
|
regulator of G-protein signalling 7 binding protein |
chr7_+_45349267 | 6.42 |
ENSMUST00000003360.10
|
Car11
|
carbonic anhydrase 11 |
chr4_-_25800238 | 6.41 |
ENSMUST00000108199.2
|
Fut9
|
fucosyltransferase 9 |
chr17_+_27160203 | 6.30 |
ENSMUST00000194598.6
|
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr6_+_22875494 | 6.29 |
ENSMUST00000090568.7
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
chr5_-_44956932 | 6.18 |
ENSMUST00000199261.2
ENSMUST00000199534.5 |
Ldb2
|
LIM domain binding 2 |
chr2_+_25132941 | 5.95 |
ENSMUST00000114355.2
ENSMUST00000060818.2 |
Rnf208
|
ring finger protein 208 |
chr7_+_15863679 | 5.93 |
ENSMUST00000211649.2
|
Slc8a2
|
solute carrier family 8 (sodium/calcium exchanger), member 2 |
chr14_-_94128065 | 5.88 |
ENSMUST00000192221.6
ENSMUST00000195826.6 ENSMUST00000193901.6 ENSMUST00000194056.2 |
Pcdh9
|
protocadherin 9 |
chr14_-_55150547 | 5.88 |
ENSMUST00000228495.3
ENSMUST00000228119.3 ENSMUST00000050772.10 ENSMUST00000231305.2 |
Slc22a17
|
solute carrier family 22 (organic cation transporter), member 17 |
chr13_+_91609169 | 5.87 |
ENSMUST00000004094.15
ENSMUST00000042122.15 |
Ssbp2
|
single-stranded DNA binding protein 2 |
chr6_-_124840824 | 5.81 |
ENSMUST00000046893.10
ENSMUST00000204667.2 |
Gpr162
|
G protein-coupled receptor 162 |
chr7_-_126548671 | 5.77 |
ENSMUST00000106339.2
ENSMUST00000052937.12 |
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr6_+_114259596 | 5.71 |
ENSMUST00000032454.8
|
Slc6a1
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
chr11_+_92989229 | 5.47 |
ENSMUST00000107859.8
ENSMUST00000107861.8 ENSMUST00000042943.13 ENSMUST00000107858.9 |
Car10
|
carbonic anhydrase 10 |
chr9_+_43957241 | 5.45 |
ENSMUST00000214627.2
|
Thy1
|
thymus cell antigen 1, theta |
chr16_+_95059121 | 5.42 |
ENSMUST00000113858.3
|
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr16_-_74208395 | 5.38 |
ENSMUST00000227347.2
|
Robo2
|
roundabout guidance receptor 2 |
chr2_-_115896279 | 5.37 |
ENSMUST00000110907.8
ENSMUST00000110908.9 |
Meis2
|
Meis homeobox 2 |
chr15_+_98530236 | 5.37 |
ENSMUST00000109150.9
|
Cacnb3
|
calcium channel, voltage-dependent, beta 3 subunit |
chr1_+_158189831 | 5.36 |
ENSMUST00000193042.6
ENSMUST00000046110.16 |
Astn1
|
astrotactin 1 |
chr15_-_37792635 | 5.35 |
ENSMUST00000090150.11
ENSMUST00000150453.2 |
Ncald
|
neurocalcin delta |
chr7_-_24771717 | 5.31 |
ENSMUST00000003468.10
|
Grik5
|
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
chr12_-_11486544 | 5.28 |
ENSMUST00000072299.7
|
Vsnl1
|
visinin-like 1 |
chrX_-_135769285 | 5.28 |
ENSMUST00000058814.7
|
Rab9b
|
RAB9B, member RAS oncogene family |
chr11_-_97590460 | 5.23 |
ENSMUST00000103148.8
ENSMUST00000169807.8 |
Pcgf2
|
polycomb group ring finger 2 |
chr5_+_43829631 | 5.23 |
ENSMUST00000125866.4
|
Cc2d2a
|
coiled-coil and C2 domain containing 2A |
chr1_+_42734889 | 5.22 |
ENSMUST00000054883.4
|
Pou3f3
|
POU domain, class 3, transcription factor 3 |
chr9_+_43956969 | 5.21 |
ENSMUST00000215809.2
|
Thy1
|
thymus cell antigen 1, theta |
chr19_+_8641369 | 5.20 |
ENSMUST00000035444.10
ENSMUST00000163785.2 |
Chrm1
|
cholinergic receptor, muscarinic 1, CNS |
chr17_+_37356854 | 5.07 |
ENSMUST00000025338.16
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr13_-_55635851 | 5.05 |
ENSMUST00000109921.9
ENSMUST00000109923.9 ENSMUST00000021950.15 |
Dbn1
|
drebrin 1 |
chr11_-_61344818 | 5.04 |
ENSMUST00000060255.14
ENSMUST00000054927.14 ENSMUST00000102661.4 |
Rnf112
|
ring finger protein 112 |
chr5_-_44957016 | 4.95 |
ENSMUST00000199256.5
|
Ldb2
|
LIM domain binding 2 |
chr18_+_38088597 | 4.95 |
ENSMUST00000070709.9
ENSMUST00000177058.8 ENSMUST00000169360.9 ENSMUST00000163591.9 ENSMUST00000091932.12 |
Rell2
|
RELT-like 2 |
chr9_+_40597297 | 4.95 |
ENSMUST00000034522.8
|
Clmp
|
CXADR-like membrane protein |
chr19_-_5040344 | 4.93 |
ENSMUST00000056129.9
|
Npas4
|
neuronal PAS domain protein 4 |
chr17_+_26028059 | 4.92 |
ENSMUST00000045692.9
|
Fbxl16
|
F-box and leucine-rich repeat protein 16 |
chr7_+_127345909 | 4.89 |
ENSMUST00000033081.14
|
Fbxl19
|
F-box and leucine-rich repeat protein 19 |
chr8_+_63404228 | 4.88 |
ENSMUST00000118003.8
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr11_+_94881861 | 4.86 |
ENSMUST00000038696.12
|
Ppp1r9b
|
protein phosphatase 1, regulatory subunit 9B |
chr15_+_103411461 | 4.86 |
ENSMUST00000023132.5
|
Pde1b
|
phosphodiesterase 1B, Ca2+-calmodulin dependent |
chr2_-_127498129 | 4.85 |
ENSMUST00000028853.7
|
Mal
|
myelin and lymphocyte protein, T cell differentiation protein |
chr15_-_79048674 | 4.79 |
ENSMUST00000230261.2
ENSMUST00000040019.5 |
Sox10
|
SRY (sex determining region Y)-box 10 |
chr15_+_83676140 | 4.78 |
ENSMUST00000172115.8
ENSMUST00000172398.2 |
Mpped1
|
metallophosphoesterase domain containing 1 |
chr8_-_9821021 | 4.76 |
ENSMUST00000208933.2
ENSMUST00000110969.5 |
Fam155a
|
family with sequence similarity 155, member A |
chr19_+_44282113 | 4.75 |
ENSMUST00000026221.7
|
Scd2
|
stearoyl-Coenzyme A desaturase 2 |
chr11_-_70924288 | 4.73 |
ENSMUST00000238695.2
|
6330403K07Rik
|
RIKEN cDNA 6330403K07 gene |
chr5_+_9316097 | 4.73 |
ENSMUST00000134991.8
ENSMUST00000069538.14 ENSMUST00000115348.9 |
Elapor2
|
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
chr2_-_180956293 | 4.70 |
ENSMUST00000103045.4
|
Stmn3
|
stathmin-like 3 |
chr15_-_37792237 | 4.66 |
ENSMUST00000168992.8
ENSMUST00000148652.9 |
Ncald
|
neurocalcin delta |
chr3_+_156267429 | 4.62 |
ENSMUST00000074015.11
|
Negr1
|
neuronal growth regulator 1 |
chr9_-_56542908 | 4.60 |
ENSMUST00000114256.2
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr7_+_4693603 | 4.59 |
ENSMUST00000120836.8
|
Brsk1
|
BR serine/threonine kinase 1 |
chr13_+_54519161 | 4.57 |
ENSMUST00000026985.9
|
Cplx2
|
complexin 2 |
chr7_+_3439144 | 4.55 |
ENSMUST00000182222.8
|
Cacng8
|
calcium channel, voltage-dependent, gamma subunit 8 |
chr11_+_101066867 | 4.53 |
ENSMUST00000103109.4
|
Cntnap1
|
contactin associated protein-like 1 |
chr1_+_172168764 | 4.48 |
ENSMUST00000056136.4
|
Kcnj10
|
potassium inwardly-rectifying channel, subfamily J, member 10 |
chr7_-_46782448 | 4.48 |
ENSMUST00000033142.13
|
Ptpn5
|
protein tyrosine phosphatase, non-receptor type 5 |
chr11_-_94967623 | 4.46 |
ENSMUST00000145671.2
ENSMUST00000120375.8 |
Itga3
|
integrin alpha 3 |
chr11_-_42070517 | 4.44 |
ENSMUST00000206105.2
ENSMUST00000153147.3 |
Gabra1
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
chr7_+_3381434 | 4.43 |
ENSMUST00000092891.6
|
Cacng7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr8_+_113296675 | 4.40 |
ENSMUST00000034225.7
ENSMUST00000118171.8 |
Cntnap4
|
contactin associated protein-like 4 |
chr17_-_36014892 | 4.37 |
ENSMUST00000097333.10
ENSMUST00000003628.13 |
Ddr1
|
discoidin domain receptor family, member 1 |
chr7_+_44091822 | 4.37 |
ENSMUST00000058667.15
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr7_-_78228116 | 4.36 |
ENSMUST00000206268.2
ENSMUST00000039431.14 |
Ntrk3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr7_-_119801327 | 4.30 |
ENSMUST00000033198.6
|
Crym
|
crystallin, mu |
chr2_+_27332336 | 4.28 |
ENSMUST00000209765.2
|
Brd3os
|
bromodomain containing 3, opposite strand |
chr16_+_95058895 | 4.27 |
ENSMUST00000113859.8
ENSMUST00000152516.2 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr10_-_127024641 | 4.26 |
ENSMUST00000218654.2
|
Arhgef25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr4_+_101407608 | 4.24 |
ENSMUST00000094953.11
ENSMUST00000106933.2 |
Dnajc6
|
DnaJ heat shock protein family (Hsp40) member C6 |
chrX_-_94209913 | 4.23 |
ENSMUST00000113873.9
ENSMUST00000113876.9 ENSMUST00000199920.5 ENSMUST00000113885.8 ENSMUST00000113883.8 ENSMUST00000196012.2 ENSMUST00000182001.8 ENSMUST00000113878.8 ENSMUST00000113882.8 ENSMUST00000182562.2 |
Arhgef9
|
CDC42 guanine nucleotide exchange factor (GEF) 9 |
chr1_-_75254989 | 4.23 |
ENSMUST00000039534.11
|
Resp18
|
regulated endocrine-specific protein 18 |
chr7_+_18915086 | 4.22 |
ENSMUST00000120595.8
ENSMUST00000048502.10 |
Eml2
|
echinoderm microtubule associated protein like 2 |
chr11_+_97732108 | 4.22 |
ENSMUST00000155954.3
ENSMUST00000164364.2 ENSMUST00000170806.2 |
B230217C12Rik
|
RIKEN cDNA B230217C12 gene |
chr5_+_125609440 | 4.22 |
ENSMUST00000031446.7
|
Tmem132b
|
transmembrane protein 132B |
chr16_+_34975245 | 4.21 |
ENSMUST00000114913.3
|
Adcy5
|
adenylate cyclase 5 |
chr6_+_107506678 | 4.21 |
ENSMUST00000049285.10
|
Lrrn1
|
leucine rich repeat protein 1, neuronal |
chr4_-_68872585 | 4.19 |
ENSMUST00000030036.6
|
Brinp1
|
bone morphogenic protein/retinoic acid inducible neural specific 1 |
chr2_-_115895528 | 4.18 |
ENSMUST00000028639.13
ENSMUST00000102538.11 |
Meis2
|
Meis homeobox 2 |
chr11_-_69728560 | 4.15 |
ENSMUST00000108634.9
|
Nlgn2
|
neuroligin 2 |
chr6_-_124834670 | 4.12 |
ENSMUST00000023958.10
|
P3h3
|
prolyl 3-hydroxylase 3 |
chr8_+_63404395 | 4.12 |
ENSMUST00000119068.8
|
Spock3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
chr3_+_102642516 | 4.11 |
ENSMUST00000119902.6
|
Tspan2
|
tetraspanin 2 |
chr14_+_76714350 | 4.11 |
ENSMUST00000140251.9
|
Tsc22d1
|
TSC22 domain family, member 1 |
chr7_+_57240894 | 4.09 |
ENSMUST00000039697.14
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr1_-_168259710 | 4.01 |
ENSMUST00000072863.6
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr3_-_80710097 | 3.99 |
ENSMUST00000075316.10
ENSMUST00000107745.8 |
Gria2
|
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
chr15_-_99425555 | 3.98 |
ENSMUST00000231171.2
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr3_+_102642272 | 3.94 |
ENSMUST00000196611.5
|
Tspan2
|
tetraspanin 2 |
chr9_+_104446957 | 3.94 |
ENSMUST00000077190.7
|
Cpne4
|
copine IV |
chr5_-_129030111 | 3.93 |
ENSMUST00000196085.5
|
Rimbp2
|
RIMS binding protein 2 |
chr1_-_168259839 | 3.93 |
ENSMUST00000188912.7
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr11_+_69920956 | 3.86 |
ENSMUST00000232115.2
|
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr1_-_55265925 | 3.86 |
ENSMUST00000027121.15
ENSMUST00000114428.3 |
Rftn2
|
raftlin family member 2 |
chr18_-_25886908 | 3.85 |
ENSMUST00000115816.3
ENSMUST00000223704.2 |
Celf4
|
CUGBP, Elav-like family member 4 |
chr18_-_15196612 | 3.81 |
ENSMUST00000168989.9
|
Kctd1
|
potassium channel tetramerisation domain containing 1 |
chr6_-_119307685 | 3.78 |
ENSMUST00000112756.8
ENSMUST00000068351.14 |
Lrtm2
|
leucine-rich repeats and transmembrane domains 2 |
chr9_+_37450551 | 3.76 |
ENSMUST00000002008.7
ENSMUST00000215957.2 ENSMUST00000215271.2 |
Vsig2
|
V-set and immunoglobulin domain containing 2 |
chr14_-_29443792 | 3.75 |
ENSMUST00000022567.9
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr9_+_70586232 | 3.73 |
ENSMUST00000067880.13
|
Adam10
|
a disintegrin and metallopeptidase domain 10 |
chr11_-_3321307 | 3.72 |
ENSMUST00000101640.10
ENSMUST00000101642.10 |
Limk2
|
LIM motif-containing protein kinase 2 |
chr17_+_35295909 | 3.72 |
ENSMUST00000013910.5
|
Ly6g6e
|
lymphocyte antigen 6 complex, locus G6E |
chr2_+_121188195 | 3.71 |
ENSMUST00000125812.8
ENSMUST00000078222.9 ENSMUST00000125221.3 ENSMUST00000150271.8 |
Ckmt1
|
creatine kinase, mitochondrial 1, ubiquitous |
chr2_+_16361081 | 3.70 |
ENSMUST00000028081.13
|
Plxdc2
|
plexin domain containing 2 |
chr11_+_96822213 | 3.69 |
ENSMUST00000107633.2
|
Prr15l
|
proline rich 15-like |
chr9_-_83688294 | 3.69 |
ENSMUST00000034796.14
ENSMUST00000183614.2 |
Elovl4
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
chr7_-_78227518 | 3.67 |
ENSMUST00000195262.6
ENSMUST00000193002.6 |
Ntrk3
|
neurotrophic tyrosine kinase, receptor, type 3 |
chr2_+_121189091 | 3.66 |
ENSMUST00000000317.13
ENSMUST00000129130.3 |
Ckmt1
|
creatine kinase, mitochondrial 1, ubiquitous |
chrX_+_165127688 | 3.64 |
ENSMUST00000112223.8
ENSMUST00000112224.8 ENSMUST00000112229.9 ENSMUST00000112228.8 ENSMUST00000112227.9 ENSMUST00000112226.3 |
Gpm6b
|
glycoprotein m6b |
chrX_-_135116192 | 3.63 |
ENSMUST00000113120.2
ENSMUST00000113118.2 ENSMUST00000058125.9 |
Bex1
|
brain expressed X-linked 1 |
chr7_+_4693759 | 3.62 |
ENSMUST00000048248.9
|
Brsk1
|
BR serine/threonine kinase 1 |
chr9_+_104446682 | 3.61 |
ENSMUST00000057742.15
|
Cpne4
|
copine IV |
chr1_+_75456173 | 3.60 |
ENSMUST00000113575.9
ENSMUST00000148980.2 ENSMUST00000050899.7 ENSMUST00000187411.2 |
Tmem198
|
transmembrane protein 198 |
chr6_-_92458324 | 3.57 |
ENSMUST00000113445.2
|
Prickle2
|
prickle planar cell polarity protein 2 |
chr9_+_8900460 | 3.56 |
ENSMUST00000070463.10
ENSMUST00000098986.4 |
Pgr
|
progesterone receptor |
chr1_+_78488499 | 3.54 |
ENSMUST00000012331.7
|
Mogat1
|
monoacylglycerol O-acyltransferase 1 |
chr14_+_55120777 | 3.53 |
ENSMUST00000022806.10
|
Bcl2l2
|
BCL2-like 2 |
chr15_-_34679321 | 3.52 |
ENSMUST00000040791.9
|
Nipal2
|
NIPA-like domain containing 2 |
chr3_+_55149947 | 3.52 |
ENSMUST00000167204.8
ENSMUST00000054237.14 |
Dclk1
|
doublecortin-like kinase 1 |
chr5_-_86616849 | 3.51 |
ENSMUST00000101073.3
|
Tmprss11a
|
transmembrane protease, serine 11a |
chr5_-_44956981 | 3.50 |
ENSMUST00000070748.10
|
Ldb2
|
LIM domain binding 2 |
chr3_-_89152320 | 3.50 |
ENSMUST00000107464.8
ENSMUST00000090924.13 |
Trim46
|
tripartite motif-containing 46 |
chr6_-_85479840 | 3.50 |
ENSMUST00000161546.2
ENSMUST00000161078.8 |
Fbxo41
|
F-box protein 41 |
chr12_-_72455708 | 3.50 |
ENSMUST00000078505.14
|
Rtn1
|
reticulon 1 |
chr6_-_138399896 | 3.49 |
ENSMUST00000161450.8
ENSMUST00000163024.8 ENSMUST00000162185.8 |
Lmo3
|
LIM domain only 3 |
chr14_-_52553764 | 3.48 |
ENSMUST00000135523.5
|
Sall2
|
spalt like transcription factor 2 |
chr3_+_92840279 | 3.48 |
ENSMUST00000046234.5
|
Lce3b
|
late cornified envelope 3B |
chr9_-_81515865 | 3.48 |
ENSMUST00000183482.2
|
Htr1b
|
5-hydroxytryptamine (serotonin) receptor 1B |
chr15_-_85466009 | 3.47 |
ENSMUST00000023015.15
|
Wnt7b
|
wingless-type MMTV integration site family, member 7B |
chr3_-_72965136 | 3.47 |
ENSMUST00000059407.9
|
Slitrk3
|
SLIT and NTRK-like family, member 3 |
chr19_+_46490123 | 3.46 |
ENSMUST00000026008.9
|
Trim8
|
tripartite motif-containing 8 |
chr8_-_72124359 | 3.45 |
ENSMUST00000177517.8
ENSMUST00000030170.15 |
Unc13a
|
unc-13 homolog A |
chr6_-_18514801 | 3.41 |
ENSMUST00000090601.12
|
Cttnbp2
|
cortactin binding protein 2 |
chr15_+_82136598 | 3.40 |
ENSMUST00000136948.3
|
1500009C09Rik
|
RIKEN cDNA 1500009C09 gene |
chrX_+_40490353 | 3.40 |
ENSMUST00000165288.2
|
Gria3
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
chr14_+_68321302 | 3.40 |
ENSMUST00000022639.8
|
Nefl
|
neurofilament, light polypeptide |
chr6_-_36787096 | 3.39 |
ENSMUST00000201321.2
ENSMUST00000101534.5 |
Ptn
|
pleiotrophin |
chr13_-_99653045 | 3.39 |
ENSMUST00000064762.6
|
Map1b
|
microtubule-associated protein 1B |
chr4_+_127066667 | 3.38 |
ENSMUST00000106094.9
|
Dlgap3
|
DLG associated protein 3 |
chr11_+_87651359 | 3.38 |
ENSMUST00000039627.12
ENSMUST00000100644.10 |
Tspoap1
|
TSPO associated protein 1 |
chr7_+_30450896 | 3.37 |
ENSMUST00000182229.8
ENSMUST00000080518.14 ENSMUST00000182227.8 ENSMUST00000182721.8 |
Sbsn
|
suprabasin |
chr9_+_70586298 | 3.36 |
ENSMUST00000144537.2
|
Adam10
|
a disintegrin and metallopeptidase domain 10 |
chr1_-_168259264 | 3.36 |
ENSMUST00000176790.8
|
Pbx1
|
pre B cell leukemia homeobox 1 |
chr13_+_75237939 | 3.36 |
ENSMUST00000022075.6
|
Pcsk1
|
proprotein convertase subtilisin/kexin type 1 |
chr8_+_57908920 | 3.35 |
ENSMUST00000034023.4
|
Scrg1
|
scrapie responsive gene 1 |
chr2_+_169475436 | 3.33 |
ENSMUST00000109157.2
|
Tshz2
|
teashirt zinc finger family member 2 |
chr3_-_69767208 | 3.33 |
ENSMUST00000171529.4
ENSMUST00000051239.13 |
Sptssb
|
serine palmitoyltransferase, small subunit B |
chr2_-_110781268 | 3.33 |
ENSMUST00000099623.10
|
Ano3
|
anoctamin 3 |
chr1_-_22386016 | 3.33 |
ENSMUST00000164877.8
|
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr11_-_94967483 | 3.32 |
ENSMUST00000001548.14
|
Itga3
|
integrin alpha 3 |
chr5_+_115604321 | 3.32 |
ENSMUST00000145785.8
ENSMUST00000031495.11 ENSMUST00000112071.8 ENSMUST00000125568.2 |
Pla2g1b
|
phospholipase A2, group IB, pancreas |
chr1_+_42734051 | 3.32 |
ENSMUST00000239323.2
ENSMUST00000199521.5 ENSMUST00000176807.3 |
Pou3f3
Gm20646
|
POU domain, class 3, transcription factor 3 predicted gene 20646 |
chr15_-_98660873 | 3.32 |
ENSMUST00000156572.3
|
Arf3
|
ADP-ribosylation factor 3 |
chr4_+_118286898 | 3.30 |
ENSMUST00000067896.4
|
Elovl1
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 |
chr1_-_25868788 | 3.29 |
ENSMUST00000151309.8
|
Adgrb3
|
adhesion G protein-coupled receptor B3 |
chr1_-_25868592 | 3.29 |
ENSMUST00000135518.8
|
Adgrb3
|
adhesion G protein-coupled receptor B3 |
chr7_+_30411634 | 3.29 |
ENSMUST00000005692.14
ENSMUST00000170371.2 |
Atp4a
|
ATPase, H+/K+ exchanging, gastric, alpha polypeptide |
chr12_+_4684620 | 3.28 |
ENSMUST00000217672.2
|
Itsn2
|
intersectin 2 |
chr5_-_70999547 | 3.28 |
ENSMUST00000199705.2
|
Gabrg1
|
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
chr2_+_163280375 | 3.28 |
ENSMUST00000109420.10
ENSMUST00000109421.10 ENSMUST00000018087.13 ENSMUST00000137070.2 |
Gdap1l1
|
ganglioside-induced differentiation-associated protein 1-like 1 |
chrX_-_69408627 | 3.25 |
ENSMUST00000101509.9
|
Ids
|
iduronate 2-sulfatase |
chr10_-_127031578 | 3.24 |
ENSMUST00000038217.14
ENSMUST00000130855.8 ENSMUST00000116229.2 ENSMUST00000144322.8 |
Dtx3
|
deltex 3, E3 ubiquitin ligase |
chr19_-_8816530 | 3.24 |
ENSMUST00000096259.6
|
Gng3
|
guanine nucleotide binding protein (G protein), gamma 3 |
chr1_-_22845124 | 3.23 |
ENSMUST00000115273.10
|
Rims1
|
regulating synaptic membrane exocytosis 1 |
chr7_-_105282687 | 3.18 |
ENSMUST00000147044.4
ENSMUST00000106791.8 ENSMUST00000153371.9 ENSMUST00000106789.8 |
Trim3
|
tripartite motif-containing 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
4.7 | 14.0 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
3.2 | 22.5 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
3.1 | 9.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
2.8 | 39.6 | GO:0098953 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
2.6 | 13.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
2.3 | 7.0 | GO:0030070 | insulin processing(GO:0030070) |
2.2 | 6.6 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
2.1 | 8.5 | GO:0072021 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
2.0 | 13.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 2.0 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.0 | 5.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.0 | 5.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.9 | 5.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
1.9 | 7.7 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
1.9 | 9.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.8 | 7.4 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.7 | 7.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.7 | 5.2 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
1.7 | 10.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
1.6 | 4.9 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
1.6 | 4.9 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.6 | 6.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.5 | 7.7 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.5 | 4.5 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
1.4 | 10.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
1.4 | 9.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.4 | 1.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.4 | 4.2 | GO:0001966 | thigmotaxis(GO:0001966) |
1.4 | 2.8 | GO:0009644 | response to high light intensity(GO:0009644) |
1.3 | 8.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.3 | 5.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
1.3 | 3.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.3 | 6.4 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.3 | 5.1 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
1.2 | 6.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.2 | 7.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.2 | 1.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.2 | 6.1 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.2 | 18.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.2 | 4.7 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
1.1 | 4.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
1.1 | 4.5 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
1.1 | 1.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.1 | 12.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.1 | 3.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 4.4 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.1 | 4.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.1 | 4.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.1 | 6.4 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 3.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
1.0 | 4.2 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 4.2 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
1.0 | 10.2 | GO:0046959 | habituation(GO:0046959) |
1.0 | 2.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.0 | 8.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 3.8 | GO:0003360 | brainstem development(GO:0003360) |
0.9 | 18.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.9 | 13.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.9 | 1.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 14.0 | GO:0036065 | fucosylation(GO:0036065) |
0.9 | 10.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.9 | 2.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.9 | 0.9 | GO:0060032 | notochord regression(GO:0060032) |
0.9 | 6.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.8 | 3.4 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.8 | 9.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.8 | 2.5 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.8 | 2.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.8 | 33.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.8 | 2.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.8 | 4.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.8 | 4.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.8 | 18.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 9.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 4.6 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.8 | 6.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 4.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 2.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.8 | 1.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.7 | 6.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 2.2 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.7 | 0.7 | GO:2001107 | negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.7 | 2.2 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.7 | 3.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.7 | 1.5 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 2.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.7 | 4.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.7 | 5.6 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.7 | 1.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.7 | 1.4 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.7 | 2.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.7 | 2.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.7 | 2.1 | GO:0007210 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) serotonin receptor signaling pathway(GO:0007210) |
0.7 | 2.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.7 | 3.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.7 | 2.0 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.7 | 4.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 17.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.7 | 0.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.7 | 2.6 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.7 | 6.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 2.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 24.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.6 | 1.9 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.6 | 1.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.6 | 1.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.6 | 9.3 | GO:0099612 | protein localization to axon(GO:0099612) |
0.6 | 1.9 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.6 | 1.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.6 | 2.4 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.6 | 0.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.6 | 8.5 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.6 | 15.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 4.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 7.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 1.8 | GO:0060156 | vascular transport(GO:0010232) milk ejection(GO:0060156) |
0.6 | 3.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 4.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 2.9 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
0.6 | 16.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.6 | 1.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 10.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 25.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.6 | 4.6 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.6 | 4.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.6 | 1.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.6 | 4.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 3.4 | GO:0042891 | antibiotic transport(GO:0042891) |
0.6 | 17.9 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.6 | 8.9 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.6 | 2.2 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.6 | 2.8 | GO:0035989 | tendon development(GO:0035989) |
0.5 | 1.6 | GO:0034117 | erythrocyte aggregation(GO:0034117) regulation of erythrocyte aggregation(GO:0034118) |
0.5 | 2.2 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.5 | 2.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.5 | 11.3 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.5 | 1.6 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.5 | 1.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 2.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.5 | 5.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 1.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.5 | 1.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.5 | 13.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 4.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.5 | 2.0 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.5 | 3.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.5 | 1.5 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 0.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.5 | 4.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.5 | 3.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 2.0 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.5 | 1.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.5 | 1.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.5 | 8.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.5 | 11.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 3.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 51.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 5.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.5 | 5.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 1.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.5 | 1.8 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 3.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.3 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 8.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.4 | 1.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.4 | 15.8 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.4 | 2.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 3.9 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.4 | 2.6 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 1.7 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
0.4 | 2.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 0.9 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.4 | 3.0 | GO:0030432 | peristalsis(GO:0030432) |
0.4 | 0.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.4 | 12.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 1.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 1.3 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.4 | 0.4 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.4 | 2.5 | GO:0097394 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.4 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.4 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 1.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 2.0 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 1.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 1.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.4 | 0.8 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.4 | 1.6 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.4 | 1.2 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.4 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 2.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 3.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 | 1.5 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.4 | 1.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.4 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.4 | 1.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.4 | 2.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 1.4 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
0.3 | 7.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 1.7 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.3 | 1.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
0.3 | 1.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.3 | 4.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 2.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 2.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.3 | 1.0 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.3 | 1.3 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.3 | 3.0 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.3 | 6.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.7 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 2.3 | GO:0021767 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 1.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.3 | 0.7 | GO:0021815 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.3 | 1.0 | GO:0002730 | dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
0.3 | 7.6 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 2.0 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 1.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 1.6 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.3 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.3 | 10.0 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 1.0 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.3 | 0.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.3 | 1.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 2.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 2.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 4.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.3 | 0.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 1.2 | GO:1901003 | negative regulation of fermentation(GO:1901003) |
0.3 | 0.9 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.3 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 5.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
0.3 | 0.3 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) intestine smooth muscle contraction(GO:0014827) |
0.3 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 2.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 2.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.3 | 1.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 1.4 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.3 | 1.7 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.3 | 3.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 0.9 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 0.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 2.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 0.9 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.3 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 2.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.3 | 1.1 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.3 | 0.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.8 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.3 | 4.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 3.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.3 | 1.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.1 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.3 | 3.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.5 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 2.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 1.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 1.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.3 | 3.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 1.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.3 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 6.6 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.3 | 0.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.3 | 1.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.7 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.2 | 2.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 5.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 1.2 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.5 | GO:0002353 | plasma kallikrein-kinin cascade(GO:0002353) |
0.2 | 1.2 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 1.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 3.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.2 | 0.5 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.2 | 1.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 8.7 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.7 | GO:1903412 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
0.2 | 0.7 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.7 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.2 | 3.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 2.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.5 | GO:2000292 | regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.2 | 3.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 0.7 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 0.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 11.6 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 1.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.2 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 1.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 1.8 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 0.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.2 | 1.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.2 | 2.2 | GO:0032264 | IMP salvage(GO:0032264) |
0.2 | 0.7 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.2 | 2.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.7 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 9.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 1.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.9 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.2 | 10.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 3.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 3.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 0.8 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.2 | 2.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 3.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 4.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.2 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 1.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.8 | GO:0097274 | urea homeostasis(GO:0097274) |
0.2 | 6.1 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 1.0 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.0 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 2.2 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 1.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 1.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.8 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.2 | 1.9 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.2 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 3.5 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.8 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.2 | 6.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.9 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.6 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.2 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 0.9 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.2 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 2.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.2 | 0.4 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.2 | 1.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 2.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 2.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.5 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
0.2 | 0.5 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
0.2 | 2.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.9 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 2.6 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.2 | 5.5 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 4.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 3.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 1.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 0.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 0.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.3 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 6.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.3 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.2 | 2.3 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.5 | GO:0015881 | creatine transport(GO:0015881) |
0.2 | 10.6 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 0.2 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 1.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 4.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.1 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.2 | 1.9 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 2.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.6 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.9 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 3.3 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 3.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 1.0 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 6.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.2 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.1 | 15.4 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 2.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 1.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.4 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.1 | 2.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.1 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 1.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.1 | 1.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.5 | GO:0032888 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 1.1 | GO:0031179 | peptide modification(GO:0031179) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 3.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 1.1 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.8 | GO:0060083 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.1 | 1.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 10.9 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.1 | 1.0 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 9.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.5 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.1 | 0.2 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.3 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.7 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 9.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 4.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 4.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.1 | 1.1 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.3 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 3.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 2.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 1.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 0.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 3.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 5.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 6.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.3 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 2.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.1 | 13.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 1.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.4 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.2 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 10.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 2.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 2.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.3 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 1.0 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.3 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 1.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 1.2 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.2 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 5.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
0.1 | 0.5 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.6 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.1 | 0.5 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 6.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.1 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.1 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 1.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 1.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.4 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.7 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 2.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.1 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 2.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
0.1 | 0.1 | GO:0014820 | hypotonic response(GO:0006971) tonic smooth muscle contraction(GO:0014820) cellular hypotonic response(GO:0071476) |
0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.2 | GO:0044107 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.1 | 0.8 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.1 | 0.6 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 2.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 1.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.8 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 0.8 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:1902415 | histone H3-R17 methylation(GO:0034971) regulation of mRNA binding(GO:1902415) |
0.1 | 5.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.2 | GO:0045924 | regulation of female receptivity(GO:0045924) positive regulation of female receptivity(GO:0045925) |
0.1 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 1.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.3 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 3.5 | GO:0032963 | collagen metabolic process(GO:0032963) |
0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.3 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 3.5 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.1 | 0.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 1.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.1 | 1.4 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.2 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
0.0 | 0.3 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 1.5 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.7 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.0 | 0.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.0 | 0.2 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0060180 | female mating behavior(GO:0060180) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.2 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.0 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.3 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 1.5 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.2 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.0 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.8 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 1.2 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 1.4 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.0 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.0 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.0 | 0.0 | GO:0035332 | positive regulation of hippo signaling(GO:0035332) |
0.0 | 2.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.4 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.2 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.0 | 1.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.9 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 1.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.0 | 0.7 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.0 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.0 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 1.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 2.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.5 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
0.0 | 0.3 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 22.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
3.3 | 16.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.1 | 10.6 | GO:0044308 | axonal spine(GO:0044308) |
1.9 | 7.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.9 | 40.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 10.0 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
1.5 | 5.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.5 | 1.5 | GO:0044301 | climbing fiber(GO:0044301) |
1.4 | 4.3 | GO:0090537 | CERF complex(GO:0090537) |
1.4 | 11.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.4 | 5.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.2 | 3.6 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.2 | 17.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.1 | 2.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.1 | 31.9 | GO:1902710 | GABA receptor complex(GO:1902710) |
1.1 | 7.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.9 | 19.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.9 | 13.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.9 | 3.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.9 | 15.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 3.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.9 | 13.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 3.5 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.9 | 1.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.8 | 3.4 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
0.8 | 5.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.8 | 14.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 9.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 25.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.7 | 28.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.7 | 7.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 7.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 3.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 3.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 4.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 4.0 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 1.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.6 | 1.7 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
0.5 | 2.2 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.5 | 4.3 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 0.5 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.5 | 5.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.5 | 2.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.5 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 3.4 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.5 | 4.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.5 | 8.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 3.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.4 | 4.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 6.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 2.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 10.0 | GO:0097449 | astrocyte projection(GO:0097449) |
0.4 | 3.7 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.4 | 2.5 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.4 | 9.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.4 | 14.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.4 | 5.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 12.5 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 26.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
0.4 | 5.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 5.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 8.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 2.7 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.4 | 6.7 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 9.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 6.6 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 2.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 2.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.3 | 11.9 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 4.0 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 3.7 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.3 | 10.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 2.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 1.3 | GO:0097444 | spine apparatus(GO:0097444) |
0.3 | 1.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 0.9 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.3 | 3.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 3.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 11.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 5.6 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 19.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 8.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 2.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 36.2 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 6.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 4.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 22.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 1.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 6.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 6.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 5.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.9 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 2.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 1.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 66.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 3.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 2.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.2 | 1.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 1.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 0.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.0 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 6.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 9.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.3 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 17.8 | GO:0044309 | neuron spine(GO:0044309) |
0.2 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 3.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 2.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 6.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 2.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 31.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 4.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 23.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 8.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.2 | 1.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 2.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.4 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 1.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 9.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.7 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 5.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 19.3 | GO:0097060 | synaptic membrane(GO:0097060) |
0.1 | 1.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 8.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 8.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 4.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.4 | GO:0034456 | CURI complex(GO:0032545) UTP-C complex(GO:0034456) |
0.1 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 2.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 4.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 3.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 2.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 12.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 29.6 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 15.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 2.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 7.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 1.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 2.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 8.9 | GO:0045202 | synapse(GO:0045202) |
0.1 | 30.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 2.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 3.6 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 7.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.2 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 9.1 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 51.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 1.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 7.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.4 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
0.0 | 4.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 3.7 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 16.7 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 3.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 2.6 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 1.3 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 33.9 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
3.8 | 22.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.4 | 19.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.3 | 13.8 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.8 | 7.4 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.7 | 1.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.6 | 4.8 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
1.5 | 15.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
1.5 | 12.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.5 | 10.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.5 | 7.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 13.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.4 | 4.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.3 | 4.0 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.3 | 8.8 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
1.2 | 11.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.2 | 3.7 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
1.2 | 6.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.2 | 9.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.1 | 3.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 3.4 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
1.1 | 8.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 4.4 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.1 | 3.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.0 | 15.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 4.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.0 | 7.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.0 | 2.9 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.9 | 6.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.9 | 10.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 19.7 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.9 | 13.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.9 | 3.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.9 | 28.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 2.5 | GO:0036004 | GAF domain binding(GO:0036004) |
0.8 | 3.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.8 | 4.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.8 | 2.4 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.8 | 31.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.8 | 4.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.8 | 11.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.8 | 8.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.8 | 4.6 | GO:0004144 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
0.8 | 3.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.7 | 3.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 4.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 8.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.7 | 5.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 0.7 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.7 | 3.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.7 | 2.6 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 9.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 3.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.6 | 1.9 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.6 | 4.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.6 | 4.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.6 | 1.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.6 | 8.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 11.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 10.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.6 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.6 | 4.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 6.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.6 | 7.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.6 | 3.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.6 | 1.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 1.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.6 | 5.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 3.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 3.3 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.5 | 5.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 4.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 4.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.5 | 5.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.5 | 5.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 3.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 5.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.5 | 5.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.5 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.5 | 4.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.5 | 3.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 8.2 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 1.0 | GO:0002135 | CTP binding(GO:0002135) sulfonylurea receptor binding(GO:0017098) |
0.5 | 1.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.5 | 2.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 5.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 5.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 9.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 3.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 6.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.4 | 2.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 2.6 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 3.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.3 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.4 | 0.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.4 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.4 | 2.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.4 | 2.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.4 | 4.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 2.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.4 | 8.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.4 | 2.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.4 | 4.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 1.2 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.4 | 1.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 5.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 2.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.4 | 1.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.4 | 1.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.4 | 18.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 1.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.4 | 0.7 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.4 | 21.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 6.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 2.5 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 6.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 2.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 4.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 3.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 2.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 1.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.3 | 8.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 4.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 12.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.3 | 1.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.3 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 1.2 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.3 | 10.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 3.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 6.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 1.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 2.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 3.2 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 5.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.9 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.3 | 0.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
0.3 | 1.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 3.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 18.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 3.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 1.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.3 | 3.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 5.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 0.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.3 | 4.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 4.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.3 | 1.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 3.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 23.8 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 2.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 3.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 3.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.0 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.2 | 0.7 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.2 | 8.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 2.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.2 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.2 | 1.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.9 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.2 | 17.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 10.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.2 | 8.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 2.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 3.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 27.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 2.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 1.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 1.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 3.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 4.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 2.4 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 4.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 2.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 8.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.6 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 1.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 40.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 1.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 1.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 4.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.7 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 11.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 2.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.2 | 7.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 9.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 5.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 5.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.2 | 0.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 11.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 3.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.9 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.1 | 1.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 1.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 3.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 5.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.1 | 0.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 2.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 1.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 1.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 1.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 11.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 1.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 1.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 12.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.6 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.8 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 2.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 5.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 2.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 1.5 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 2.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.8 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.1 | 4.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 4.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 3.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.3 | GO:0004067 | asparaginase activity(GO:0004067) |
0.1 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 4.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 2.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 2.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 3.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 21.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 5.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.7 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.1 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 2.2 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 2.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 2.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 1.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 3.7 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.5 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.3 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 16.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 4.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 2.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 18.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.0 | 1.4 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 2.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 1.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.0 | GO:0003681 | bent DNA binding(GO:0003681) |
0.0 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 2.1 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.3 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 1.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.1 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.0 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.3 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.4 | GO:0015149 | monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:1901474 | L-histidine transmembrane transporter activity(GO:0005290) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 1.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.0 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 5.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 35.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 27.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 26.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 21.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 18.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 6.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 13.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 2.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 5.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 22.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 3.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 5.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 7.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 8.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 8.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 15.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 10.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 5.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 5.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 8.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 9.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 6.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 3.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 18.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 4.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 5.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 2.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 11.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 7.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 4.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.6 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 4.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 1.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 5.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 24.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.6 | 37.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.3 | 27.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.0 | 35.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.0 | 20.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 1.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
1.0 | 20.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 11.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.8 | 40.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.8 | 9.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 15.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 1.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.5 | 8.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 13.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 7.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 9.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 5.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 16.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 9.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 5.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 10.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 10.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 19.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 3.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 5.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 9.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 2.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 3.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 8.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 5.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 5.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.2 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.2 | 2.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 6.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 6.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.2 | 8.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 18.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.2 | 3.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 2.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 4.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 7.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 3.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 5.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 5.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 7.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 9.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 2.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 3.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 7.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 2.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 8.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 6.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 3.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 2.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 7.3 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.0 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.4 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |